Cathie Wood recently shared insights on the X platform, highlighting that, according to ChainCatcher, ARKInvest's research identifies healthcare as the most transformative application area for AI. The relaxation of regulations is accelerating this transformation in the healthcare sector. Significant advancements have been made in the science of evaluating drug efficacy, with research and development projects gathering evidence through various dimensions such as mechanisms of action, biomarker effects, and intermediate endpoints. This validation evidence, ranging from mechanistic data to real-world evidence, can replace the need for a second pivotal trial
source: https://www.binance.com/en/square/post/295284078956722?utm_source=BinanceNewsRSS